P

Inventor

DESJARLAIS JOHN

US87 patents
⚠️ This page may combine multiple inventors who share the name “DESJARLAIS JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

XENCOR INC

45 patents
US9856327B2Jan 2, 2018

Heterodimeric antibodies to CD3 X CD123

XENCOR INC72 citations98
US9650446B2May 16, 2017

Heterodimeric proteins

XENCOR INC44 citations98
US9605084B2Mar 28, 2017

Heterodimeric proteins

XENCOR INC74 citations98
US8802823B2Aug 12, 2014

Optimized Fc variants

XENCOR INC24 citations96
US11225528B2Jan 18, 2022

Heterodimeric antibodies that bind CD3 and tumor antigens

XENCOR INC11 citations94
US10793632B2Oct 6, 2020

Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors

XENCOR INC22 citations94
US10787518B2Sep 29, 2020

Bispecific checkpoint inhibitor antibodies

XENCOR INC15 citations94
US10584176B2Mar 10, 2020

Fc variants with increased affinity for FcγRIIc

XENCOR INC21 citations94
US10550185B2Feb 4, 2020

Bispecific heterodimeric fusion proteins containing IL-15-IL-15Rα Fc-fusion proteins and PD-1 antibody fragments

XENCOR INC29 citations94
US10526417B2Jan 7, 2020

Heterodimeric antibodies that bind CD3 and CD38

XENCOR INC27 citations94
US10428155B2Oct 1, 2019

Trispecific antibodies

XENCOR INC39 citations94
US10259887B2Apr 16, 2019

Heterodimeric antibodies that bind CD3 and tumor antigens

XENCOR INC25 citations94
US10227410B2Mar 12, 2019

Heterodimeric antibodies that bind CD3 and PSMA

XENCOR INC36 citations94
US10184000B2Jan 22, 2019

Optimized Fc variants and methods for their generation

XENCOR INC20 citations94
US9051373B2Jun 9, 2015

Optimized Fc variants

XENCOR INC40 citations94
US10501543B2Dec 10, 2019

IL15/IL15Rα heterodimeric Fc-fusion proteins

XENCOR INC13 citations92
US10227411B2Mar 12, 2019

Modulation of T cells with bispecific antibodies and FC fusions

XENCOR INC17 citations92
US10183999B2Jan 22, 2019

Optimized Fc variants and methods for their generation

XENCOR INC10 citations92
US9850320B2Dec 26, 2017

Heterodimeric antibodies to CD3 X CD20

XENCOR INC13 citations92
US9822186B2Nov 21, 2017

Bispecific antibodies that bind to CD38 and CD3

XENCOR INC17 citations92
US9353187B2May 31, 2016

Optimized FC variants and methods for their generation

XENCOR INC21 citations92
US9266966B2Feb 23, 2016

Compositions and methods for treating IgE-mediated disorders

XENCOR INC8 citations92
US9221916B2Dec 29, 2015

Compositions and methods for treating IgE-mediated disorders

XENCOR INC12 citations92
US8858937B2Oct 14, 2014

Optimized Fc variants and methods for their generation

XENCOR INC20 citations92
US9657106B2May 23, 2017

Optimized Fc variants

XENCOR INC13 citations91
US11623957B2Apr 11, 2023

Heterodimeric antibodies that bind CD3 and PSMA

XENCOR INC9 citations86
US11505595B2Nov 22, 2022

TIM-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion proteins and TIM-3 antigen binding domains

XENCOR INC9 citations86
US11319355B2May 3, 2022

Engineered IL-2 Fc fusion proteins

XENCOR INC5 citations84
US11053316B2Jul 6, 2021

Optimized antibody variable regions

XENCOR INC7 citations84
US10981992B2Apr 20, 2021

Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors

XENCOR INC6 citations84
US10982006B2Apr 20, 2021

Heterodimeric antibodies that bind fibroblast activation protein

XENCOR INC8 citations84
US10858417B2Dec 8, 2020

Heterodimeric proteins

XENCOR INC7 citations84
US10738133B2Aug 11, 2020

Heterodimeric proteins

XENCOR INC9 citations84
US10131710B2Nov 20, 2018

Optimized antibody variable regions

XENCOR INC15 citations84
US10113001B2Oct 30, 2018

Fc variants with increased affinity for FcyRIIc

XENCOR INC7 citations84
US10106624B2Oct 23, 2018

Heterodimeric proteins

XENCOR INC7 citations84
US8735547B2May 27, 2014

Optimized Fc Variants

XENCOR INC5 citations84
US11084863B2Aug 10, 2021

Targeted heterodimeric Fc fusion proteins containing IL-15 IL-15alpha and antigen binding domains

XENCOR INC7 citations83
US9663582B2May 30, 2017

Optimized Fc variants

XENCOR INC6 citations83
US9193798B2Nov 24, 2015

Optimized Fc variants and methods for their generation

XENCOR INC4 citations82
US12239688B2Mar 4, 2025

IL-15/IL-15RA heterodimeric Fc fusion proteins and uses thereof

XENCOR INC2 citations75
US11945880B2Apr 2, 2024

Heterodimeric antibodies that bind CD3 and tumor antigens

XENCOR INC1 citations73
US11859011B2Jan 2, 2024

Heterodimeric antibodies that bind CD3 and tumor antigens

XENCOR INC1 citations73
US11634506B2Apr 25, 2023

Heterodimeric proteins

XENCOR INC2 citations73
US11584794B2Feb 21, 2023

Bispecific heterodimeric fusion proteins containing IL-15-IL-15Ralpha Fc-fusion proteins and immune checkpoint antibody fragments

XENCOR INC2 citations73

LAZAR GREGORY ALAN

3 patents

DESJARLAIS JOHN

1 patent

MOORE GREGORY L

1 patent

Showing the top 50 of 87 patents by PatentIndex Score.